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AbstrACt
Objectives This feasibility study and process evaluation 
assessed the likely success of a definitive trial of 
intramedullary fixation with locked retrograde nails versus 
extramedullary fixation with fixed angle plates for fractures 
of the distal femur.
Design & setting A multicentre, parallel, two-arm, 
randomised controlled feasibility study with an embedded 
process evaluation was conducted at seven NHS hospitals 
in England. Treatment was randomly allocated in 1:1 ratio, 
stratified by centre and chronic cognitive impairment. 
Participants, but not surgeons or research staff, were 
blinded to the allocation.
Participants Patients 18 years and older with a fracture 
of the distal femur, who their surgeon believed would 
benefit from internal fixation, were eligible to take part.
Participants were allocated to receive either a retrograde 
intramedullary nail or an anatomical locking plate. 
Outcomes The primary outcomes for this feasibility 
study were the recruitment rate and completion rate of 
the EQ-5D-5L at 4 months post-randomisation. Baseline 
characteristics, disability rating index, quality of life scores, 
measurements of social support and self-efficacy, resource 
use and radiographic assessments were also collected. 
The views of patients and staff were collected during 
interviews.
results Recruitment and data completion were lower than 
expected. 23 of 82 eligible patients were recruited (nail, 
11; plate, 12). The recruitment rate was estimated as 0.42 
(95% CI 0.27 to 0.62) participants per centre-month. Data 
completeness of the EQ-5D-5L at 4 months was 61 per cent 
(95% CI 43% to 83%). The process evaluation demonstrated 
that the main barriers to recruitment were variation in 
treatment pathways across centres, lack of surgeon 
equipoise and confidence in using both interventions and 
newly formed research cultures that lacked cohesion.
Conclusions A modified trial design, with embedded 
recruitment support intervention, comparing functional 
outcome in cognitively intact adults who have sustained a 
fragility fracture of the distal femur is feasible.
Ethics approval The Wales Research Ethics Committee 5 
approved the study (ref: 16/WA/0225).
trial registration number ISRCTN92089567; Pre-results.
IntrODuCtIOn
background
Distal femur fractures have an incidence of 
10 per 100 000 and have a bimodal distri-
bution with age, with approximately 85% 
sustained by older patients after a fall from a 
standing height and the remainder sustained 
by patients after major trauma.1 2 
There is currently no consensus about the 
best way to treat these fractures. A recent 
Cochrane review identified few trials in 
this area, many using outdated implants or 
with important methodological limitations 
and suggested that future patients’ func-
tional outcomes could be improved by a 
well-designed randomised controlled trial 
comparing modern treatments.3
In a multicentre retrospective study to 
review current practices, we found that the 
treatments commonly used in the UK are 
fixation with a locked retrograde nail (nail) 
strengths and limitations of this study
 ► Mixed methodology feasibility study including a ran-
domised trial and process evaluation.
 ► Conducted at seven hospitals, including several ma-
jor trauma centres.
 ► Included qualitative interviews with participants, re-
searchers and surgeons.
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and fixation with an anatomical, angular stable plate 
(plate).4 Nails offer minimal disruption of the fracture 
site, a potential mechanical benefit from a device close to 
the axis of the femur and stimulated blood supply from 
reaming of the intramedullary canal.5 On the other hand 
fixed-angle plates are specifically designed for osteopo-
rotic bone, and the bone-plate constructs have excellent 
biomechanical properties.6 However plates require larger 
incisions and are more expensive than nails. Limited 
evidence suggests that there may be a benefit of using 
nails over plates in terms of patients’ quality of life, with 
small studies identifying differences of 0.09 and 0.1 in 
EQ-5D-5L-derived utility scores at 1 year.7 8
This study of fracture fixation with nails compared with 
plates aimed to assess the feasibility of a future definitive 
trial, and perform a process evaluation to understand the 
generalisability and likely success of a future trial.
MEthODs
Approval and oversight
The trial protocol is available in the online supplemen-
tary material and has been previously published.9 The 
conduct of the study was overseen by independent data 
safety monitoring and trial steering committees.
Inclusion criteria
Patients aged 18 and over who were admitted to one 
of seven participating NHS hospitals in England with a 
fracture of the distal femur, which their treating surgeon 
believed would benefit from internal fixation, were poten-
tially eligible to take part. Patients with a loose knee or 
hip arthroplasty requiring revision, or an arthroplasty or 
pre-existing femoral deformity that precluded nail fixa-
tion, were excluded.
All potentially eligible participants for Trial of Acute 
Femoral Fracture Fixation (TrAFFix) and their carers, 
as well as all staff involved with the study at participating 
centres, were eligible to be interviewed for the process 
evaluation.
Consent
Where patients had capacity to consent to be involved 
in the study prior to surgery, this was sought by hospital 
research teams. For patients lacking capacity to provide 
informed consent, the hospital research teams sought 
agreement from an appropriate consultee, either a nomi-
nated consultee (eg, treating surgeon who was not part 
of the research team) or a personal consultee such as 
the next of kin. Where a consultee gave agreement prior 
to surgery and the patient regained capacity following 
surgery, consent for continued participation in the study 
was sought from the patient.
During the consent process patients and carers indi-
cated their willingness to be approached for interviews 
for the process evaluation. Consent for interviews was 
sought at the start of each interview by a researcher from 
the University of Oxford.
randomisation and blinding
Following consent from the patient or agreement from 
an appropriate consultee, participants were randomised 
prior to surgery to receive either nail or plate in a 1:1 
ratio using an online randomisation system. The trial stat-
istician generated the allocation sequences. Allocations 
used fixed blocks of size 4 and were stratified by centre to 
ensure any clustering effect related to centres was distrib-
uted across arms, and by the presence of chronic cogni-
tive impairment to ensure this important effect modifier 
was distributed evenly across groups.
Participants were not informed of their allocation 
during the trial but were able to request to be informed 
of their allocation at the end of the study. Surgeons 
and research staff were not blinded. Radiographs were 
reviewed by independent assessors, however due to the 
presence of the implants they were also not blinded.
sample size
There was no sample size calculation performed, instead 
it was estimated that recruiting for 52 centre-months with 
an average of one patient per centre-month would allow 
an estimation of the recruitment rate of a future defini-
tive trial with a 95% CI of 0.73 to 1.28.
Interventions
Potential participants were reviewed in daily trauma 
meetings and operated on at the next available theatre 
time. Patients were assessed and received anaesthesia, 
analgesia and prophylactic antibiotics as per local prac-
tices. Preparation, positioning and reduction of the frac-
ture, details of incision and approach and supplementary 
fixation with wires or screws were left to the discretion of 
the treating surgeon.
For patients allocated a nail, fixation of the fracture 
was achieved with a proximally and distally locked nail 
that spanned the entire diaphysis of the femur. All nails 
were introduced retrograde through the knee joint. For 
patients allocated plates, fixation of the fracture was 
achieved with anatomical distal femoral locking-plate and 
screws, defined as those in which at least one fixed angle 
locking screw was placed distal to the fracture.
Outcome measures
The primary outcomes for this feasibility study were the 
recruitment rate and completion rate of the EQ-5D-5L10 
at 4 months post-surgery.
Screening
Participating hospitals were asked to record screening 
data for all patients admitted with a fracture of the distal 
femur during the study period. In addition, an ortho-
paedic surgeon at each participating hospital retro-
spectively reviewed admissions data and re-screened all 
admissions during the recruitment period. Similarly, 
we requested admissions data from the Trauma Audit 
and Research Network (TARN)11 in order to monitor 
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orthopaedic trainees. These data included admission 
date, diagnosis and treatment received.
Clinical and patient-reported outcomes
Baseline recordings were made of patient character-
istics, grip strength12 and Rockwood frailty scores13 as 
predictors of frailty, the level of social support available 
to patients using the medical outcomes survey social 
support survey14 and patient activation using a general 
self-efficacy questionnaire.15
EQ-5D-5L, a generic five-level health utility instrument 
used to measure health-related quality of life across five 
domains of mobility, self-care, usual activities, pain and 
depression was measured at baseline (pre-injury and 
contemporary) and 6 weeks and 4 months post-injury. 
Dementia quality of life scores (DEMQoL, and DEMQoL-
proxy when completed by a carer) were recorded for 
patients with chronic cognitive impairment, along with 
proxy-reported EQ-5D-5L scores.16 The disability rating 
index (DRI),17 which measures disability from 0 to 100 
across 12 items, was recorded at each time point for 
patients without cognitive impairment.
Radiographs taken at 6 weeks post-injury were assessed 
independently for evidence of loss of fixation, varus or 
valgus deformity >5o (deformity in the coronal plane), 
recurvatum/procurvatum >10o (deformity in the sagittal 
plane) and shortening of the femur >1 cm. Related 
medical complications occurring during the trial period 
were recorded.
In order to assess the feasibility of a health econom-
ical assessment in a larger trial, resource use data were 
measured using baseline case reporting forms (CRFs) 
(treatment costs) and a patient completed questionnaire 
at 4 months post-injury. Estimation of unit costs followed 
recent National Institute for Health and Care Excel-
lence (NICE) guidelines on costing health and social 
care services18 using the NHS reference costs19 and NHS 
Supply Chain Catalogue20 and inflated to 2017/18 prices 
using the NHS hospital & community health services 
index for health service resources.21
Analysis
Analyses were conducted in R (V.3.3.0, R Foundation 
for Statistical Computing, Vienna, Austria. https://www. 
R- project. org/) and the statistical analysis plan is avail-
able as online supplementary material. The recruitment 
rate was estimated using Poisson regression analysis, 
and the completeness of EQ-5D-5L was calculated as the 
percentage of randomised participants completing the 
EQ-5D-5L questionnaire. Given the small study group, 
treatment effects were not estimated.
Responses from the EQ-5D-5L health classifications 
were converted into an overall score using a published 
utility algorithm for the population of the UK.22
Process evaluation
A process evaluation was performed to assess imple-
mentation, mechanisms of impact and context of the 
interventions, in line with Medical Research Council 
guidelines.23 In order to inform the development of a 
definitive trial, our process evaluation also examined 
the implementation of study processes. The evaluation 
of implementation included the reach and fidelity of 
screening and the acceptability of the interventions and 
study procedures. To understand how the interventions 
produced change in outcomes, we identified relevant 
intermediate outcomes that might be associated with 
the effect of the interventions on the primary outcomes 
of interest. The context in which the intervention is 
delivered will influence outcomes. A particular focus 
in our evaluation of context considered contextual 
similarities and differences between the participating 
centres, which might have influenced the delivery of 
study procedures.
We used a mixed methodology approach using 
a variety of data sources in the process evaluation 
including qualitative interviews with patients (n=9), 
carers (n=2) and staff (n=24), screening logs, national 
datasets and a 1 day workshop with patients and public 
representatives. Interviews were based on a topic guide 
that included participants’ experience of taking part 
in TrAFFix and the experiences of staff recruiting to 
TrAFFix. Interviews were audio recorded and tran-
scribed verbatim; data were managed using NVivo 10 
(QSR International, Warrington, UK). Data were anal-
ysed inductively using a thematic analysis. Quantitative 
data were summarised using standard descriptive statis-
tical techniques. The analyses were integrated using the 
framework of a process evaluation and summarised in 
tables.
Patient & public involvement
A public representative was a member of the trial 
management committee, and was a co-applicant on 
the funding application. Patients and public represen-
tatives were consulted on the design of patient-facing 
documents via the UK Musculoskeletal Trauma patient 
and public involvement mailing list. Patient and public 
representatives were also invited to a meeting to develop 
a logical model.
Important changes to the study design
Patient’s age (50 years and older) was initially used as 
an inclusion criterion as a surrogate for likely fragility 
fracture. However following review of the screening 
data, the independent steering committee requested 
that the minimum inclusion age be lowered to 18 and 
a mechanistic determination of fragility fracture, using 
mechanism of injury, be assessed as part of the feasi-
bility study to explore the impact of this modification 
on recruitment rate.
Instead of utilising the algorithm by Herdman et al24 to 
convert EQ-5D-5L to EQ-5D-3L utility as mentioned in 
the health economics analysis plan, the NICE-approved 
method of calculating utility values was performed 
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Recruitment opened in October 2016 and closed in 
August 2017, with a total of 54.8 centre-months of 
recruitment measured. Twenty three participants were 
randomised into the study, giving an estimated recruit-
ment rate of 0.42 (95% CI 0.27 to 0.62) participants per 
centre-month. The flow of participants through the trial 
is described in figure 1.
Differences in surgical practices were identified across 
participating hospitals. For example the numbers of 
patients treated non-operatively varied between 0 and 18 
patients (0% to 44% of patients screened at each centre), 
and the proportion of patients excluded due to surgeon 
preference varied between 40% and 70%. A breakdown 
of recruitment and reasons for exclusion for each site is 
given in online supplementary Table S1.
Of the 173 patients screened, the most common reason 
that patients were not recruited were surgeon preference for 
either a nail or plate (23%; 39/173), presence of a pre-ex-
isting arthroplasty (19%; 33/173) and a decision to treat 
the patient non-operatively (18%; 31/173). The number of 
patients treated non-operatively was higher than anticipated, 
but confirmed by data from retrospective screening of all 
admissions, and by data from TARN. The baseline charac-
teristics of randomised participants in each group were well 
matched and are described in table 1. Following the change 
of the minimum inclusion age to 18 years old one patient 
under 50 was randomised, this patient was aged 40 to 45 
years, was injured by fall from over 2 m, and had no reported 
bone health problems.
Clinical outcomes
Of the 23 participants randomised the EQ-5D-5L ques-
tionnaire was completed by 20 (87%, 95% CI 65% to 
97%), 15 (65%, 95% CI 43% to 83%) and 14 (61%, 
95% CI 39% to 80%) patients at baseline, 6 weeks and 
4 months respectively. There were insufficient numbers of 
patients to draw any meaningful conclusions about treat-
ment effects between groups.
The mean scores across each time point for EQ-5D-5L, 
DRI and DEMQoL are reported in table 2. Independent 
assessors at participating sites were asked to review any 
radiographs taken at 6 week follow-up appointments, the 
results of assessments are described in table 3, along with 
a summary of the post-operative complications reported 
during the 4 month follow-up period.
Power analysis
We estimated the sample size necessary to power a defin-
itive study using a patient reported outcome such as DRI. 
Using a minimum important difference of 8 points and 
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SD of 21 points defined in previous studies and in line 
with values reported here,25 and an attrition rate of 30%, 
a sample of 210 participants per group (420 in total) 
would be needed to reject the null hypothesis with proba-
bility (power) 0.9 and type I error rate of 5%.
Process evaluation
A summary of the complete findings of the process evalu-
ation is presented in the online supplementary table S2.




Age (years); mean (SD; n) 70.1 (13.6; 10) 78.7 (14.9; 11)
Grip strength (kg); mean (SD; 
n)
16.8 (4.6; 4) 18.7 (1.2; 3)
Rockwood frailty score (1 to 9); 
mean (SD; n)
3.7 (2.2; 10) 4.5 (2.1; 12)
Pre-Op AMTS 
  <7; n (%) 3 (27.3) 1 (8.3)
  7+; n (%) 4 (36.4) 7 (58.3)
Post-Op AMTS 
  <7; n (%) 0 (0.0) 1 (8.3)
  7+; n (%) 2 (18.2) 3 (25.0)
Gender 
  Female; n (%) 7 (63.6) 9 (75)
  Male; n (%) 4 (36.4) 3 (25)
Ethnicity 
  Indian; n (%) 1 (9.1) 0 (0)
  White; n (%) 9 (81.8) 11 (91.7)
Diabetes 
  No; n (%) 5 (45.5) 9 (75)
  Yes; n (%) 5 (45.5) 2 (16.7)
Regular smoker 
  No; n (%) 9 (81.8) 10 (83.3)
  Yes; n (%) 1 (9.1) 1 (8.3)
Living arrangement 
  Care home; n (%) 1 (9.1) 1 (8.3)
  Live alone; n (%) 3 (27.3) 4 (33.3)
  Live with relatives; n (%) 1 (9.1) 1 (8.3)
  Live with wife/husband/
partner; n (%)
5 (45.5) 5 (41.7)
Treatment details 
Time from admission to 
surgery (days); median (IQR)
2 (1 to 3) 2 (1 to 3)
Mechanism of injury 
  Fall from<2 m (%) 11 (100%) 12 (100%)
Fracture classification* 
  A1; n (%) 7 (63.6) 5 (41.7)
  A2; n (%) 3 (27.3) 2 (16.7)
  A3; n (%) 0 (0) 1 (8.3)
  B1; n (%) 0 (0) 1 (8.3)
  C2; n (%) 1 (9.1) 1 (8.3)
  C3; n (%) 0 (0) 2 (16.7)
Periprosthetic fracture 
  No; n (%) 8 (72.7) 9 (75)
  Yes; n (%) 3 (27.3) 3 (25)
ASA Grade 




  Three or four; n (%) 8 (72.8) 6 (50)
Method fixation 
  Nail; n (%) 10 (90.9) 1 (8.3)
  Plate; n (%) 0 (0) 11 (91.7)
  Other; n (%) 1 (9.1) 0 (0)
Grade operating surgeon 
  Consultant; n (%) 7 (63.6) 8 (66.7)
  SAS; n (%) 1 (9.1) 1 (8.3)
  ST3+; n (%) 3 (27.3) 3 (25)
Where totals do not sum to column totals then it indicates that 
there were missing data.
Reported percentages are based on the full population.
*AO/OTA classification of peri-articular fractures.
Table 1 Continued 





Pre-injury: mean (SD; n)
  EQ-5D-5L 0.59 (0.29; 10) 0.56 (0.22; 10)
  DRI 45.4 (36.7; 9) 67.5 (10.1; 10)
  DEMQoL proxy 87 (0; 1) –
  DEMQoL self – 78.2 (0; 1)
Post-injury: mean (SD; n)
  EQ-5D-5L −0.05 (0.28; 10) −0.04 (0.16; 10)
  DRI 86.5 (15.5; 9) 92.5 (5.3; 10)
  DEMQoL proxy 97 (0; 1) –
  DEMQoL self – 84 (0, 1)
6 weeks: mean (SD; n)
  EQ-5D-5L 0.35 (0.30; 10) 0.05 (0.16; 5)
  DRI 78.0 (16.9; 9) 87.3 (3.1; 5)
  DEMQoL proxy 87 (0; 1) –
  DEMQoL self – –
4 months: mean (SD; n)
  EQ-5D-5L 0.38 (0.36; 9) 0.37 (0.41; 5)
  DRI 60.9 (23.1; 8) 82.8 (2.9; 4)
  DEMQoL proxy 89 (0; 1) –
  DEMQoL self – –
*Indicates no data were available. DEMQoL, Dementia quality of 
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During the 10 months recruitment period, 91 patients 
were screened and recorded on screening logs, usually 
by a research associate (RA). Of these, 54 were eligible to 
participate in the study. Retrospective review of screening 
by orthopaedic surgeons at each participating centre 
found a further 82 unscreened patients with distal femur 
fractures including 31 eligible patients who were not 
included on the screening logs. The number of patients 
added after rescreening varied by centre with between 0 
and 34 patients added. At interview, staff emphasised that 
there were few patients eligible for the study, suggesting 
that they were unaware that potentially eligible patients 
were being missed.
‘With the TrAFFix study, well we just never had the 
numbers coming through and I think the only two 
that we actually missed were during weekends and I 
think one was when I was on annual leave’ Staff (RA) 
19
The differing levels of experience of the research 
teams and research culture, evident in the approaches 
to screening, recruitment and data collection, within the 
centres may explain differences in the number of patients 
missed from screening logs. In some centres, not all 
surgeons within the team screened and identified eligible 
patients, while in other centres patients deemed ineli-
gible might not have been recorded in the screening logs.
Fidelity of screening
Interviews with research staff revealed that several centres 
relied on research teams to screen patients as the clinical 
team tended not to notify the research team of eligible 
patients. Screening was facilitated by the presence of the 
research team in the daily trauma meeting, as they were 
able to prompt the clinical teams to consider whether 
patients were eligible. The attendance of the research 
team in this meeting varied between the centres due 
to staffing and other commitments. Additionally, some 
centres found it difficult for the clinical team to keep 
the study in mind as potentially eligible patients were 
infrequent.
Acceptability of the interventions
At interview, some staff described an unwillingness from 
surgeons to randomise patients. They felt that some 
surgeons lacked equipoise and believed that only one 
method of fixation was appropriate for any given fracture.
‘you would never do the other thing for this frac-
ture’ Staff (Surgeon) 8
However, some staff reported that surgeons’ prefer-
ences for one of the two interventions were based on 
their surgical skill and experience.
‘Some surgeons, they only know how to do a plate 
and what you will see is plate plate plate plate so it 
comes down to also what you are good at sometimes 
and you don’t want something else.’ Staff (Surgeon) 
16
In contrast some surgeons were able to accept commu-
nity equipoise (uncertainty within the expert medical 
community),26 accepting their less preferred intervention 
if required.
Acceptability of the study procedures
Consent
Participants and carers were rarely able to describe the 
study in their own words but they tended to recall or 
recognise the interventions.
‘Yes, because one is on the outside and one is a rod 
through the middle isn’t it’ Participant 4
Several participants described struggling to engage 
with information about the study around the time of 
their surgery explaining that they were not ‘in a fit state’ 
(participant 5) to ask questions or were ‘trying to so hard 
to be normal’ (participant 3).
Interviews with staff showed that they described the 
study to patients in simple terms. Randomisation, for 
example was explained using phrases such as ‘50/50’ or 
‘computer decides.’ When explaining the study, staff also 
emphasised that both treatments are routinely used and 
that their surgeon was happy for them to receive either 
intervention, as they believed these were important to 
patients.
Table 3 Summary of 6 week postoperative radiograph 





Six week radiographic 
assessment: n (%)
  Loss of fixation 1 (9.1) 1 (8.3)
  Varus/valgus >5o 10 (90.9) 5 (41.7)
  Recurvatum >10o 1 (9.1) 0 (0)
  Procurvatum >10o 1 (9.1) 0 (0)
  Shortening >1 cm 2 (18.2) 0 (0)
Postoperative complications: n 
(%)
Nail Plate
  Wound infection 0 (0) 0 (0)
  Venous thromboembolism 0 (0) 0 (0)
  Pneumonia 1 (9.1) 0 (0)
  Urinary tract infection 1 (9.1) 0 (0)
  Cerebrovascular accident 0 (0) 0 (0)
  Myocardial infarction 1 (9.1) 0 (0)
  Blood transfusion 2 (18.2) 2 (16.7)
  Malunion 0 (0) 0 (0)
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‘They’re going to have surgery anyway and then like 
I said if you say we don’t know which the better one 
is and the surgeon is happy, I think is the key point is 
that the surgeon is happy for them to be part of the 
study’ Staff (RA) 1
The majority of staff found involving relatives in the 
discussion about the study to be helpful as it enabled 
patients to be supported in their decision-making. In 
contrast, a minority of staff felt that it was easier to consent 
patients to studies when their relatives were not involved 
as they could be protective and involving them could lead 
to more potential participants declining.
‘Sometimes you can find it easier if you approach 
them to try and time it around their visiting hours 
and so they’ve got a relative with them and so you 
can kind of talk to them as a family and a lot more 
patients feel more comfortable with that’ Staff (RA) 7
Two of seven patients who were entered into the study 
under nominated consultee agreement withdrew when 
they were approached to consent to continue in the study 
after surgery. One of these seven patients participated in 
an interview. She acknowledged that she ‘wasn’t sufficiently 
with it to give an opinion’ (participant 1) prior to surgery.
Randomisation
The majority of staff found randomisation was acceptable 
to patients, explaining that it was considered acceptable 
because of the explanation that the surgeon thought 
both treatments were appropriate. Two members of staff, 
in contrast, found patients disliked randomisation and 
wanted their surgeons to choose the treatment that was 
most appropriate for them.
When randomisation was described to participants 
during their interview, they accepted it or seemed indif-
ferent towards it. Several participants, however, demon-
strated therapeutic misconception: ‘when a research subject 
fails to appreciate the distinction between the imperatives of 
clinical research and of ordinary treatment, and therefore inac-
curately attributes therapeutic intent to research procedures’.27 
They believed that they or their relative would receive the 
most appropriate intervention for them.
‘I think I prefer the one they done. I mean I didn’t 
have a say in it, they decided what they thought was 
best, you know but I preferred the one they done 
definitely.’ Participant 6
Blinding
A minority of participants were told of their treatment 
allocation following surgery or when they returned for 
follow-up appointments. Some staff felt that blinding 
participants to their treatment allocation would be diffi-
cult as patients could see their allocation in the letter sent 
to their general practitioner or X-rays, or they may be 
told by another member of staff. Some staff wanted to tell 
patients who asked which intervention they were allocated 
as one explained, ‘I wouldn’t be particularly comfortable, on 
a personal level… I would want to tell them what they have had’ 
(surgeon 8).
Case reporting forms
Research staff found that completing CRFs with the 
patient group could be challenging, as most patients 
were frail and often had long-term medical problems. 
They felt the questionnaires were lengthy and tiring for 
patients who often needed support completing them. 
They tended to ask the questions as part of a conversation 
to pull out the information for the questionnaire as they 
found some patients were unable to express their expe-
rience using the responses in the scales. Several RAs felt 
that where patients were wary of participating in studies 
this was usually due to the burden of follow-up rather 
than a dislike of randomisation or preference for one of 
the interventions.
‘Some of the questions you have to try to put it into 
different words for them to understand, some of the 
questions don’t make any sense to them’ Staff (RA) 2
Mechanisms of impact
We identified intermediate outcomes that might be asso-
ciated with the effect of the interventions on the primary 
outcomes of interest. Associations between the factors 
identified here, the interventions and the outcome of 
interest will be assessed in a definitive trial. Factors that 
might influence patients’ recovery after a distal femur frac-
ture were identified by patients and public representatives 
and from data collected from interviews with participants 
and staff. Factors fell into three groups: existing factors 
relating to the characteristics of patients including their 
age, cognition and psychological factors such as self-ef-
ficacy; injury and treatment factors including the injury 
itself and factors relating to the surgeon and centre in 
which the treatment was delivered; post-discharge factors 
including rehabilitation provided, living arrangements 
and availability of support at home both from social care 
and from family. These factors are presented in online 
supplementary table S3.
Context
Contextual differences between the participating centres 
may have led to differences in how the study was imple-
mented. Surgeons’ working in departments where several 
trials were running may have been more engaged in 
research and more inclined to participate.
‘However, that’s changing and we’ve got a lot more of 
the consultants on board now and a lot more involved 
in the trial… there’s consultants that are running tri-
als in hand orthopaedics, the more elective side of 
things but also do the trauma lists and so are getting 
more involved with what’s going on in research and 
therefore they’re more happy to be involved in it and 
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Some staff felt that differences in the size of the 
research team, their workload and working hours could 
influence how the study was implemented. For example, 
the presence of RAs in the trauma meeting could facil-
itate screening but required RAs to start work before 
eight, which was not possible in every centre.
‘I’m keen to see what is going to happen when we 
do get the other research nurses going to the trauma 
meeting because I feel that that’s going to make a big 
difference and I think our recruitment will increase 
quite a lot but I might be completely wrong in think-
ing that.’ Staff (RA) 4
‘I think if we didn’t have enough studies running to 
have a fully funded research team then it would be 
tricky.’ Staff (surgeon) 20
Meanwhile, some centres relied on one or part-time 
RAs. This can result in patients being missed either when 
the RA was away or because they were struggling with 
their workload.
‘There was nobody in (to recruit) this Friday just 
gone and it can happen because I’ve got to be every-
where.’ Staff (RA) 16
DIsCussIOn
We have reported a randomised feasibility study, and to 
our knowledge the first with an embedded process eval-
uation, to plan a future trial of the treatment of patients 
with a fracture of the distal femur. We found the number 
of eligible patients screened closely matched the original 
estimate of 1.5 patients per centre-month. The recruit-
ment rate into the trial, however, fell substantially short 
of this. The process evaluation identified very significant 
surgeon-related barriers to recruitment into the study. 
Research cultures were found to vary widely between 
centres; a positive culture was a strong predictor of 
improved recruitment performance.
This study has challenged many of the assump-
tions which underpinned the development of the trial 
protocol. The recruited population had a much lower 
prevalence of cognitive impairment, less frailty and was 
physiologically fitter than the previously characterised 
incident fracture population.4 Surgeons were actively 
selecting fitter patients for operative treatment in a way 
that we had not anticipated. The eligible population is 
therefore somewhat different than we originally expected 
and hence the design for the definitive trial can be modi-
fied in important ways.
It is clear that research staff can and do miss potentially 
eligible patients if the working practices at hospitals do 
not facilitate full integration of the research staff into 
the clinical team. Although the specifics vary between 
hospitals, crucial decision points exist within the clin-
ical process, such as daily trauma meetings, into which 
research staff must be integrated in order to be able to 
engage clinicians in research studies.
Surgeons reported a lack of their confidence in the 
management of this relatively uncommon fracture, the 
operative treatment of which is perceived to be tech-
nically demanding. The combination of this common 
anxiety and some individuals’ lack of equipoise, posed 
a very significant barrier to recruitment into this study. 
Similar challenges have been previously identified in 
other surgical trials.28 29 Interventions that have included 
training on community equipoise have been successful 
when targeted at multidisciplinary teams and surgeons, 
improving both clinicians’ confidence and potentially 
recruitment rates,30 31 though definitive evidence is 
lacking.32 We propose that a modified protocol that 
includes an intervention to promote awareness and 
understanding of the existing community equipoise will 
be able to overcome these surgeon-related barriers to 
recruitment.
Our findings demonstrate that the trial design tested in 
this feasibility study is unlikely to be successful on a larger 
scale. However, the recruitment rate of 0.42 participants 
per centre-month is in line with that reported by the 
FixDT trial, which tested similar interventions for treating 
fractures of the tibia and delivered to target and budget.25
We propose a modified definitive trial with a further 
internal pilot to confirm recruitment rates; this will be 
based on the findings of this feasibility study, with an inte-
grated recruitment intervention to support surgeons in 
their decision-making to recruit participants.
A future study may choose to exclude the small number 
of patients with chronic cognitive impairment to simplify 
trial procedures for research staff or reduce the number 
and length of questionnaires to reduce the burden on 
participants and improve retention rates. Similarly a 
future study may consider a trial design that accounts for 
surgeons’ treatment preferences during the allocation of 
treatment to improve surgeon participation and willing-
ness to randomise.
We conclude that a trial comparing functional outcome 
in cognitively intact patients aged 18 years or older who 
have sustained a fragility fracture of the distal femur, 
defined as a fall from standing height, treated with a nail 
or plate, is feasible with appropriate mitigation strategies 
incorporated to avoid failure.
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